Efficacy of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients With High Viral Load But Slight Aminotransferase Elevation
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 20 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 29 Jan 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2018 as reported by ClinicalTrials.gov record.
- 29 Jan 2015 Planned primary completion date changed to 1 Jan 2018 as reported by ClinicalTrials.gov record.